Half-life Extension Service by Genetic Manipulation
Reported by Gemini Smith | February 23rd, 2024 @ 02:20 AM
Studies conducted recently indicate that a molecule can become highly protease resistant in vivo by substituting just one amino acid. Long-acting interferon beta preparation has made use of the point mutation of interferon. A phase 1 trial was initiated for an enhanced somatropin formulation based on genetic alteration. Numerous successes attest to the fact that point mutation has emerged as a novel technique for improving the pharmacokinetics of proteins and is frequently employed in therapeutic protein research. The drug development market has high expectations for half-life extension by genetic manipulation as a unique, practical, and one-stop solution for half-life extension.
No comments found
Please Sign in or create a free account to add a new ticket.
With your very own profile, you can contribute to projects, track your activity, watch tickets, receive and update tickets through your email and much more.
Create your profile
Help contribute to this project by taking a few moments to create your personal profile. Create your profile »
.